Correlation Engine 2.0
Clear Search sequence regions

  • adults (1)
  • antibodies (2)
  • blood (1)
  • cardiovascular diseases (1)
  • CD14 (2)
  • CD16 (2)
  • female (1)
  • humans (1)
  • Long- Living (10)
  • macrophages (5)
  • monocytes (9)
  • peptides (2)
  • plasma (2)
  • protein human (1)
  • receptors (2)
  • th2 cells (1)
  • volunteers (1)
  • Sizes of these terms reflect their relevance to your search.

    Long-Living Individuals (LLIs) delay aging and are less prone to chronic inflammatory reactions. Whether a distinct monocytes and macrophages repertoire is involved in such a characteristic remains unknown. Previous studies from our group have shown high levels of the host defense BPI Fold Containing Family B Member 4 (BPIFB4) protein in the peripheral blood of LLIs. Moreover, a polymorphic variant of the BPIFB4 gene associated with exceptional longevity (LAV-BPIFB4) confers protection from cardiovascular diseases underpinned by low-grade chronic inflammation, such as atherosclerosis. We hypothesize that BPIFB4 may influence monocytes pool and macrophages skewing, shifting the balance toward an anti-inflammatory phenotype. We profiled circulating monocytes in 52 LLIs (median-age 97) and 52 healthy volunteers (median-age 55) using flow cytometry. If the frequency of total monocyte did not change, the intermediate CD14++CD16+ monocytes counts were lower in LLIs compared to control adults. Conversely, non-classical CD14+CD16++ monocyte counts, which are M2 macrophage precursors with an immunomodulatory function, were found significantly associated with the LLIs' state. In a differentiation assay, supplementation of the LLIs' plasma enhanced the capacity of monocytes, either from LLIs or controls, to acquire a paracrine M2 phenotype. A neutralizing antibody against the phosphorylation site (ser 75) of BPIFB4 blunted the M2 skewing effect of the LLIs' plasma. These data indicate that LLIs carry a peculiar anti-inflammatory myeloid profile, which is associated with and possibly sustained by high circulating levels of BPIFB4. Supplementation of recombinant BPIFB4 may represent a novel means to attenuate inflammation-related conditions typical of unhealthy aging. Copyright © 2020 Ciaglia, Montella, Lopardo, Scala, Ferrario, Cattaneo, Carrizzo, Malovini, Madeddu, Vecchione and Puca.


    Elena Ciaglia, Francesco Montella, Valentina Lopardo, Pasqualina Scala, Anna Ferrario, Monica Cattaneo, Albino Carrizzo, Alberto Malovini, Paolo Madeddu, Carmine Vecchione, Annibale Alessandro Puca. Circulating BPIFB4 Levels Associate With and Influence the Abundance of Reparative Monocytes and Macrophages in Long Living Individuals. Frontiers in immunology. 2020;11:1034

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32547549

    View Full Text